Torrent Pharmaceuticals Ltd Analyst Rating
based on 29 analysts
66.67%
Buy
20.00%
Hold
13.33%
Sell
Based on 29 analysts offering long term price targets for Torrent Pharmaceuticals Ltd. An average target of ₹3591.55
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Share analysis
Torrent Pharmaceuticals Ltd price forecast by 29 analysts
Upside of3.53%
High
₹4232
Target
₹3591.55
Low
₹2930
Torrent Pharmaceuticals Ltd target price ₹3591.55, a slight upside of 3.53% compared to current price of ₹3437. According to 29 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Torrent Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2026:25.77%
Forecast
Actual
Including amortisation and stock based compensations
Torrent Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2026:58.50%
Forecast
Actual
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹3,421.4Day's Price Range₹3,515.3552 Week's Low
52 Week's High
₹2,113.852-Week Price Range₹3,590.7
| Returns % | |
| 1 Month Return | + 11.84 % |
| 3 Month Return | + 0.33 % |
| 1 Year Return | + 58.03 % |
| Market Stats | |
| Previous Close | ₹3,469.15 |
| Open | ₹3,476.25 |
| Volume | 3.58L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,14,453.72Cr |
Torrent Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 65.15 |
| PEG Ratio | 4.8 |
| Market Cap | ₹1,14,453.72 Cr |
| P/B Ratio | 12.89 |
| EPS | 48.94 |
| Dividend Yield | 1.08 |
| Sector | Pharmaceuticals |
| ROE | 20.43 |
Torrent Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹1,14,453.72 Cr | 54.31% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
| HOLD | ₹1,55,292.48 Cr | 44.39% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
| HOLD | ₹41,786.88 Cr | 4.53% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
| HOLD | ₹29,060.56 Cr | -0.46% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
| BUY | ₹1,18,913.09 Cr | 44.4% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
Torrent Pharmaceuticals Ltd Mutual Fund Holdings
About Torrent Pharmaceuticals Ltd
The company is focused on producing high-quality, affordable medicines for the treatment of a wide range of diseases. Its top products include cardiovascular drugs, antibiotics, anti-diabetic drugs, anti-inflammatory drugs, and anti-infective drugs. Popular brands include Cadila, Torleva, Torlip, and Torleva XR.
Share Price: ₹3437.00 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹1,14,453.72Cr as of today
Revenue: ₹2,831.00Cr as on September 2024 (Q3 24)
Net Profit: ₹453.00Cr as on September 2024 (Q3 24)
Listing date: 03 Nov, 1994
Chairperson Name: Sudhir Mehta
| Organisation | Torrent Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Shows Strong Growth Potential - 19 Dec, 2024
Torrent Pharmaceuticals Ltd has seen a significant rise, up 61.34% over the past year. Analysts suggest a buy with a target price of ₹1,010-1,030, anticipating further gains of 10-12%. The stock is currently up 2.43% today.HSBC Maintains Positive Outlook on Torrent Pharmaceuticals - 11 Dec, 2024
HSBC retains a positive outlook on Torrent Pharmaceuticals, projecting strong performance in 2025 due to new launches and the company's ability to navigate industry challenges.Torrent Pharmaceuticals Acquires Anti-Diabetes Brands - 05 Dec, 2024
Torrent Pharmaceuticals announced the acquisition of three anti-diabetes brands from Boehringer Ingelheim, enhancing its portfolio in the growing SGLT-2 inhibitor market. The company's net profit also saw a significant increase.Torrent Pharma Acquires Anti-Diabetic Brands from BI - 04 Dec, 2024
Torrent Pharmaceuticals has signed an agreement to acquire three anti-diabetic brands from Boehringer Ingelheim, with completion expected by March 2025. This move strengthens Torrent's diabetes care portfolio in a growing market.Torrent Pharma Faces Tax Penalty, Stock Rallies - 29 Nov, 2024
Torrent Pharmaceuticals received a Rs 2.32 crore penalty from the Income Tax Department but remains optimistic about a favorable appeal outcome. Despite this, the stock price surged, reflecting investor confidence and a significant increase in market capitalization.Torrent Pharma Reports Strong Q3 Results - 27 Nov, 2024
Torrent Pharmaceuticals reported a 13.42% increase in net sales to Rs 2,434 crore for September 2024, with net profit rising 40.67% to Rs 460 crore. EBITDA also grew by 21.7%. The company's EPS increased to Rs 13.60. Torrent Pharma shares have delivered 21.48% returns over the last six months and 55.15% over the past year.Torrent Pharma Gains from USFDA's VAI Classification - 22 Nov, 2024
Torrent Pharmaceuticals' shares rose after receiving a Voluntary Action Indicated (VAI) classification from the USFDA for its Pithampur facility, confirming successful inspection closure.
Insights on Torrent Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 14.22% to 14.46% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, TORNTPHARM stock has moved up by 1.6%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 57.1% return, outperforming this stock by 1.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 71.25% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 15.3%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 2.88K Cr → 2.87K Cr (in ₹), with an average decrease of 0.4% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 4.35% to 3.69% in Sep 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 457.0 Cr → 453.0 Cr (in ₹), with an average decrease of 0.9% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 7.26% to 7.21% in Sep 2024 quarter
Torrent Pharmaceuticals Ltd Financials
Index Inclusions
Torrent Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.25% | 0.00 | |
| Foreign Institutions | 14.46% | 1.68 | |
| Mutual Funds | 3.69% | ||
| Retail Investors | 7.21% | ||
| Others | 3.4% | 16.12 |
Torrent Pharmaceuticals Ltd Key Indicators
Torrent Pharmaceuticals Ltd Valuation
Torrent Pharmaceuticals Ltd in the last 5 years
Lowest (31.60x)
April 2, 2018
Industry (56.23x)
December 19, 2024
Today (65.15x)
December 19, 2024
Highest (73.85x)
April 3, 2019
Torrent Pharmaceuticals Ltd Earnings and Dividends
Torrent Pharmaceuticals Ltd Earnings Results
Torrent Pharmaceuticals Ltd’s net profit jumped 17.36% since last year same period to ₹453Cr in the Q2 2024-2025. On a quarterly growth basis, Torrent Pharmaceuticals Ltd has generated -0.88% fall in its net profits since last 3-months.
Read More about Earnings ResultsTorrent Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Torrent Pharmaceuticals Ltd has declared dividend of ₹6 - translating a dividend yield of 1.05%.
Read More about Dividends
Torrent Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Torrent Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Torrent Pharmaceuticals Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Torrent Pharmaceuticals Ltd shares.
Torrent Pharmaceuticals Ltd (TORNTPHARM) share price today is ₹3437
Torrent Pharmaceuticals Ltd is listed on NSE
Torrent Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Torrent Pharmaceuticals Ltd is ₹3515.35.
- Today’s lowest price of Torrent Pharmaceuticals Ltd is ₹3421.4.
PE Ratio of Torrent Pharmaceuticals Ltd is 65.15
PE ratio = Torrent Pharmaceuticals Ltd Market price per share / Torrent Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Torrent Pharmaceuticals Ltd(TORNTPHARM) is 3.58L.
Today’s market capitalisation of Torrent Pharmaceuticals Ltd(TORNTPHARM) is ₹114453.72Cr.
| Torrent Pharmaceuticals Ltd(TORNTPHARM | Price |
|---|---|
52 Week High | ₹3590.7 |
52 Week Low | ₹2113.8 |
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹3437. It is down -4.28% from its 52 Week High price of ₹3590.7
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹3437. It is up 62.60% from its 52 Week Low price of ₹2113.8
| Torrent Pharmaceuticals Ltd(TORNTPHARM | Returns |
|---|---|
1 Day Returns | -32.15% |
1 Month Returns | 11.84% |
3 Month Returns | 0.33% |
1 Year Returns | 58.03% |